Growlife (PHOT) versus Its Rivals Critical Contrast

Risk and Volatility

Growlife has a beta of 2.3, suggesting that its stock price is 130% more volatile than the S&P 500. Comparatively, Growlife’s rivals have a beta of 1.22, suggesting that their average stock price is 22% more volatile than the S&P 500.

Valuation and Earnings

This table compares Growlife and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Growlife	N/A	-$4.48 million	0.00
Growlife Competitors	$2.77 billion	$80.45 million	11.17

Growlife’s rivals have higher revenue and earnings than Growlife. Growlife is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Growlife and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Growlife	N/A	N/A	N/A
Growlife Competitors	-5.54%	0.73%	0.04%

Institutional and Insider Ownership

40.3% of shares of all “CONSM PD – MISC DIS” companies are held by institutional investors. 2.8% of Growlife shares are held by company insiders. Comparatively, 22.3% of shares of all “CONSM PD – MISC DIS” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Growlife rivals beat Growlife on 7 of the 9 factors compared.

Growlife Company Profile

GrowLife, Inc. focuses on the functional mushroom business. It processes, stores, markets, distributes, and sells fresh and dried mushroom products. The company was founded in 2012 and is headquartered in Kirkland, Washington.